BIO-TECHNE CORP (TECH:NASDAQ)
$56.17 0.63 (1.1343%)
Analysed BIO-TECHNE CORP (TECH:NASDAQ) News Sources
Assessing Bio-Techne (TECH) Valuation After COMET Spatial Biology Platform Expansion
02-04-2026
yahoo.com
CONMED, Bruker, Waters Corporation, Avantor, and Bio-Techne Stocks Trade Down, What You Need To Know
27-03-2026
yahoo.com
Q4 Research Tools & Consumables Earnings: Bio-Techne (NASDAQ:TECH) Earns Top Marks
26-03-2026
yahoo.com
Bio-Techne Advances Spatial Biology with Modular Expansion of COMET™ Suite
25-03-2026
yahoo.com
How Is Bio-Techne's Stock Performance Compared to Other Biotechnology Stocks
20-03-2026
barchart.com
Evolve Announces March 2026 Distributions for UltraYield ETFs and Certain Evolve Funds
18-03-2026
yahoo.com
Should You Continue to Hold Bio-Techne Stock in Your Portfolio?
17-03-2026
yahoo.com
Assessing Bio‑Techne (TECH) Valuation After Institutional Buying Earnings Beat And New AI Drug Discovery Push
13-03-2026
yahoo.com
Is Bio-Techne Stock a Buy, Sell, or Hold After a Wealth Manager Dumps Its Entire Stake?
13-03-2026
fool.com
3 Cash-Producing Stocks with Open Questions
13-03-2026
yahoo.com
What is the current price of BIO-TECHNE CORP (TECH:NASDAQ)?
The current price of BIO-TECHNE CORP (TECH:NASDAQ) is $56.17.
BIO-TECHNE CORP (TECH:NASDAQ) absolute price change since previous trading day?
The absolute price change of BIO-TECHNE CORP (TECH:NASDAQ) since the previous trading day is $0.63.
BIO-TECHNE CORP (TECH:NASDAQ) percentage price change since previous trading day?
The percentage price change of BIO-TECHNE CORP (TECH:NASDAQ) since the previous trading day is 1.1343%.
What is the most recent average sentiment score for BIO-TECHNE CORP (TECH:NASDAQ)?
The most recent average sentiment score for BIO-TECHNE CORP (TECH:NASDAQ) is 71 out of 100.
What is the most recent average sentiment for BIO-TECHNE CORP (TECH:NASDAQ)?
The most recent sentiment for BIO-TECHNE CORP (TECH:NASDAQ) is .
SEC-8K** Filing Available For BIO-TECHNE CORP (TECH:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.